Morphology and function of lymphocytes expanded in granular lymphocyte leukemia
Morphology and function of lymphocytes expanded in granular lymphocyte leukemia
批准号:
63480280
负责人:
OSHIMI Kazuo
金额:
$3.52万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1988
资助国家:
日本
项目状态:
已结题
起止时间:
1988 至 1989
中文摘要
点击翻译按钮获取中文摘要
英文摘要
(1) Immunological characteristics of granular lymphocytes (GL).Lymphocytes expanded in the peripheral blood in patients with granular lymphocyte proliferative disorders (GLPD) are divided into CD3+ T-cell type and CD3-16+ NK-cell type. The incidence of T- GLPD is 64%, the number being lower than western countries. GL in T-GLPD usually lack non-MHC- restricted cytotoxicity and possess ADCC, whereas those in NK-GLPD possess both non-MHC-restricted and ADCC cytotoxicity. ADCC of T-GLPD is inhibited by the addition of anti-CD3 and anti-CD8 monoclonal antibodies (mAb), suggesting that CD3 and CD8 antigens regulate ADCC in T-GLPD. GL express IL-2 receptor (R)beta chain al one , and the proliferation of GL is mediated thorough this R in autocrine and paracrine fashion. Anti-IL-2Pbeta mAb inhibits GL proliferation.(2) Ultrastructure of GLWhen gamma delta-TCR-positive GL and K562 target cells are mixed, the GL enter into K562 cells. This phenomenon is called emperipolesis. Emperipolesis is not found in alpha beta-TCR-positive T cells or NK cells. Further characterization of emperipolesis is under investigation using gamma delta- T-cell clones.(3) Colony assayGL obtained from patients with GLPD and pure red-cell aplasia (PRCA) inhibit normal donor-derived CFU-E colonies, and the supernatants of GL also inhibit the colony formation. Since anti-interferon gamma- antibody added in the CFU-E culture system abrogates the GL-mediated CFU-E inhibition, it is likely IFN-gamma and/or related substance may be responsible for the inhibition.(4) Analysis of TCR genesMost patients with T-GLPD exhibit monoclonal rearrangements of TCR-beta and gamma genes, whereas those with NK-GLPD remain in germ-line configuration.
期刊论文(40)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Kazuo Oshimi: "Granular lymphocyte proliferative disorders: Report of 12 cases and review of the literature" Leukemia 2:617-627, 1988.
Kazuo Oshimi:“颗粒淋巴细胞增殖性疾病:12 例报告和文献综述”Leukemia 2:617-627,1988。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuo Oshimi et al.: "Ti(WT31)-negative, CD3-positive, large granular lymphocyte leukemia with nonspecific cytotoxicity" Blood 71:923-931, 1988.
Kazuo Oshimi 等人:“Ti(WT31) 阴性、CD3 阳性、具有非特异性细胞毒性的大颗粒淋巴细胞白血病”Blood 71:923-931,1988。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuo Oshimi et al.: "Perforin gene expression in granular lymphocyte proliferative disorders." Blood. 75. 704-708 (1990)
Kazuo Oshimi 等人:“颗粒淋巴细胞增殖性疾病中的穿孔素基因表达。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shigeru Hoshino: "Flow cytometric analysis of expression of interleukin 2 receptor β chain(p70-75)on various leukemic cells." Blood. in press.
Shigeru Hoshino:“各种白血病细胞上白细胞介素 2 受体 β 链 (p70-75) 表达的流式细胞术分析。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kazuo Oshimi: "CTL triggering via CD16 is regulated by CD3 and CD8 antigens:Studies with TCR-αβ^+/cd3^+16^+ and TCR-γδ^+/CD3^+16^+ granular" Submitted.
Kazuo Oshimi:“通过 CD16 触发的 CTL 受 CD3 和 CD8 抗原调节:TCR-αβ^+/cd3^+16^+ 和 TCR-γδ^+/CD3^+16^+ 颗粒的研究”已提交。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 20 条
Etiology, pathopysiology and treatment of NK cell-lineage leukemias and lymphomas
-
批准号:07457234
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.86万
-
财政年份:1995
-
负责人:OSHIMI Kazuo
-
依托单位:
Induction of specific cytotoxicity for autologous leukemic cells by the use of keller T cells and bispecific antibodies
-
批准号:02454522
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.3万
-
财政年份:1990
-
负责人:OSHIMI Kazuo
-
依托单位:
IL-2-activated lymphocytes lytic for autologous leukemia and lymphoma cells: some problems on their clinical application.
-
批准号:61480262
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$2.37万
-
财政年份:1986
-
负责人:OSHIMI Kazuo
-
依托单位: